Betulinic-acid-Lupatic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Betulinic-acid-Lupatic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Betulinic-acid-Lupatic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
Betulinic-acid-Lupatic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBetulinic acidCat. No.: HY-10529CAS No.: 472-15-1Synonyms: Lupatic acid; Betulic acid分式: CHO分量: 456.7作靶點(diǎn): Apoptosis; Topoisomerase; HIV; Autophagy; Mitophagy作通路: Apoptosis; Cell Cycle/DNA Damage; Anti-infection; Autophagy儲(chǔ)存式: 4C

2、, protect from light* In solvent : -80C, 6 months; -20C, 1 month (protect fromlight)溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 60 mg/mL (131.38 mM; Need ultrasonic)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.47 mM); Suspended solution; Need ultrasonic2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubi

3、lity: 2.5 mg/mL (5.47 mM); Suspended solution; Need ultrasonic3. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (5.47 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Betulinic acid種天然的五環(huán)三萜類化合物,為真核細(xì)胞拓?fù)洚悩?gòu)酶 I (topoisomerase I) 的抑制劑,IC50值為 5 M,具有抗炎,抗瘧疾,抗

4、艾滋病和抗腫瘤等活性。IC50 & Target Topoisomerase I HIV-15 M (IC50) 1.4 M (EC50)體外研究 Betulinic acid is a eukaryotic topoisomerase I inhibitor, with an IC50 of 5 M, and prevents topoisomerase I-DNA interaction 1. Betulinic acid (10, 20, 40, 80, and 160 M) significantly suppresses MDA-MB-231 cellviability in a t

5、ime- and dose-dependent manner after treatment for 24 or 48 h. Betulinic acid (20, 40 M)causes decrease in Bcl-2 expression of MDA-MB-231 cells. Betulinic acid also induces morphologicalchanges of MDA-MB-231 cells at 20 M, and leads to ultrastructure changes of MDA-MB-231 cells at 40 M2. Betulinic a

6、cid shows anti-HIV activities, with an EC50 of 1.4 M in acutely infected H9 lymphocytes 4.體內(nèi)研究 Betulinic acid (10 and 30 mg/kg, p.o.) significantly abrogates colon shortening, and reduces malondialdehyde(MDA) and lipid hydroperoxide levels in dextran sulfate sodium (DSS)-induced colitis in mice. Bet

7、ulinic acid(30 mg/kg, p.o.) restores superoxide dismutase (SOD), catalase activity and glutathione (GSH) content tocontrol levels in DSS-induced colitis in mice. Betulinic acid (30 mg/kg, p.o.) also inhibits the DSS-inducedincrease in inflammatory markers. Betulinic acid (3, 10, 30 mg/kg, p.o.) supp

8、resses acetic acid-inducedwrithing responses and mustard oil (MO)-induced visceral nociception in mice 3.PROTOCOLCell Assay 2 CCK-8 is used in the assay. MDA-MB-231 cells are cultured in 96-well plates at a density of 2 103cells/well and then treated with DMSO vehicle or various concentrations of Be

9、tulinic acid ranging from 5 Mto 160 M in 100 L of medium for the indicated times. After the treatment period, the medium in each well isreplaced with 110 L of medium containing 10 L of the CCK-8 mixture, and the plates are incubated for 1 hand 30 min at 37C. The absorbance at a wavelength of 450 nm

10、is measured with a microplate reader 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Female Swiss albino mice are administered vehicle (5% v/v DMSO in peanut oil) or Betulinic acid (3, 10 or 30Administration 3 mg/kg) in vehicle, orally. After 1

11、 h, acetic acid (300 mg/kg) is administered by intraperitoneal route andnumber of writhing response of each animal is counted for 20 min by an observer who is blind to thetreatments. Writhing response is when animal rubs its abdomen on surface of table/floor with elongation ofthe body and extension

12、of the hind limbs 3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn)2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemE Green Chem. 2019 May. Fuel. 2018 Dec 15, 234:110-119. J Mol Med (Berl). 2019 Jun 14. Microb Cell Fact. 2019 May 3;18(1):77.S

13、ee more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Chowdhury AR, et al. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the majorfunctional group responsible and development of more potent derivatives. Med Sci Monit. 2002 Jul

14、;8(7):BR254-65.2. Gao Y, et al. Betulinic acid induces apoptosis and ultrastructural changes in MDA-MB-231 breast cancer cells. Ultrastruct Pathol. 2018Jan-Feb;42(1):49-54.3. Kalra J, et al. Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice. Naunyn Schmiedebergs ArchPharmacol. 2017 Dec 26.4. Hashimoto F, et al. Anti-AIDS agents-XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives.Bioorg Med Chem. 1997

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論